Sanara MedTech
Nina Bionda is an accomplished professional with extensive experience in research and development, currently serving as the VP of Research and Development at Sanara MedTech since September 2022. Prior to this role, Nina held various positions at iFyber from September 2015 to August 2022, including Director of Research and Director of Microbiological Services, where responsibilities included supporting customer acquisition and leading pre-clinical in vitro testing initiatives. Nina's academic background includes a Ph.D. in Chemistry/Biochemistry from Florida Atlantic University and a Bachelor's degree in Biotechnology/Biochemical Engineering from the University of Zagreb. Additionally, significant research contributions were made as a Postdoctoral Research Scientist at the University of Rochester and as a Pre-Doctoral Research Fellow at the Torrey Pines Institute for Molecular Studies, showcasing expertise in peptide synthesis and antimicrobial research.
This person is not in any offices
Sanara MedTech
With our focus on improving patient outcomes with evidence-based healing solutions, Sanara MedTech Inc. develops, markets and distributes surgical, wound care and skin care products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our primary products are sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech sells and distributes CellerateRX® Surgical Activated Collagen® Powder to the surgical market and BIAKŌS™ Antimicrobial Skin and Wound Cleanser, Irrigation Solution, and Wound Gel, HYCOL® Hydrolyzed Collagen, and PULSAR II™ Advanced Wound Irrigation System (AWI™) to the wound care market.